These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7420270)

  • 21. Rational brain tumor chemotherapy. The interaction of drug and tumor.
    Groothuis DR; Blasberg RG
    Neurol Clin; 1985 Nov; 3(4):801-16. PubMed ID: 3908896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status.
    Liu HL; Yang HW; Hua MY; Wei KC
    Neurosurg Focus; 2012 Jan; 32(1):E4. PubMed ID: 22208897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug delivery strategies for the treatment of malignant gliomas.
    Allhenn D; Boushehri MA; Lamprecht A
    Int J Pharm; 2012 Oct; 436(1-2):299-310. PubMed ID: 22721856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.
    Matsukado K; Inamura T; Nakano S; Fukui M; Bartus RT; Black KL
    Neurosurgery; 1996 Jul; 39(1):125-33; discussion 133-4. PubMed ID: 8805148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transporter-based delivery of anticancer drugs to the brain: improving brain penetration by minimizing drug efflux at the blood-brain barrier.
    On NH; Miller DW
    Curr Pharm Des; 2014; 20(10):1499-509. PubMed ID: 23789953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective change of blood flow in experimental brain tumor with induced hypertension.
    Matsuura H; Ikeda Y; Imaya H; Nakazawa S
    Surg Neurol; 1987 May; 27(5):433-6. PubMed ID: 3563857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Regional blood flow of experimental brain tumors with special reference to effects of chemotherapy and radiotherapy].
    Nagashima T; Matsutani M; Tamura A; Orii H
    No To Shinkei; 1985 Mar; 37(3):287-94. PubMed ID: 3860212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving drug delivery to primary and metastatic brain tumors: strategies to overcome the blood-brain barrier.
    Parrish KE; Sarkaria JN; Elmquist WF
    Clin Pharmacol Ther; 2015 Apr; 97(4):336-46. PubMed ID: 25669487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microvascular permeability in induced astrocytomas and peritumor neuropil of rat brain. A high-voltage electron microscope-protein tracer study.
    Shivers RR; Edmonds CL; Del Maestro RF
    Acta Neuropathol; 1984; 64(3):192-202. PubMed ID: 6496036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound.
    Timbie KF; Afzal U; Date A; Zhang C; Song J; Wilson Miller G; Suk JS; Hanes J; Price RJ
    J Control Release; 2017 Oct; 263():120-131. PubMed ID: 28288892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacologic bases of chemotherapy of brain tumors in children].
    Vassal G
    Bull Cancer; 1990; 77(7):699-713. PubMed ID: 2207360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of dexamethasone on experimental brain tumors: I. Transcapillary transport and blood flow in RG-2 rat gliomas.
    Molnar P; Lapin GD; Groothuis DR
    J Neurooncol; 1995; 25(1):19-28. PubMed ID: 8523086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic strategies to improve drug delivery across the blood-brain barrier.
    Azad TD; Pan J; Connolly ID; Remington A; Wilson CM; Grant GA
    Neurosurg Focus; 2015 Mar; 38(3):E9. PubMed ID: 25727231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Future of convection-enhanced delivery in the treatment of brain tumors.
    Bidros DS; Liu JK; Vogelbaum MA
    Future Oncol; 2010 Jan; 6(1):117-25. PubMed ID: 20021213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug delivery to CNS tumors.
    Levin VA; Landahl HD; Patlak CS
    Cancer Treat Rep; 1981; 65 Suppl 2():19-25. PubMed ID: 7346143
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacological blood-brain barrier modification for selective drug delivery.
    Cloughesy TF; Black KL
    J Neurooncol; 1995 Nov; 26(2):125-32. PubMed ID: 8787854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors.
    Inamura T; Nomura T; Bartus RT; Black KL
    J Neurosurg; 1994 Nov; 81(5):752-8. PubMed ID: 7931623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of dose intensity in neuro-oncology clinical trials: summary report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium.
    Doolittle ND; Anderson CP; Bleyer WA; Cairncross JG; Cloughesy T; Eck SL; Guastadisegni P; Hall WA; Muldoon LL; Patel SJ; Peereboom D; Siegal T; Neuwelt EA
    Neuro Oncol; 2001 Jan; 3(1):46-54. PubMed ID: 11305417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?
    Gampa G; Vaidhyanathan S; Sarkaria JN; Elmquist WF
    Pharmacol Res; 2017 Sep; 123():10-25. PubMed ID: 28634084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.